Basic Information
| LncRNA/CircRNA Name | TCONS_00026907 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | qPCR, Western blot, Luciferase reporter assays |
| Sample | cervical cancer tissues, cell lines (HeLa and SiHa) |
| Expression Pattern | up-regulated |
| Function Description | Results showed that TCONS_00026907 level was significantly higher in cervical cancer tissues compared to noncancerous tissues and the survival rate was lower in the high expression group. |
| Pubmed ID | 28544557 |
| Year | 2017 |
| Title | LncRNA??CONS_00026907 is involved in the progression and prognosis of cervical cancer through inhibiting miR??43??p |
External Links
| Links for TCONS_00026907 | GenBank HGNC NONCODE |
| Links for cervical cancer | OMIM COSMIC |